Literature DB >> 8027144

Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump.

F S Santori1, A Vitullo, M Stopponi, N Santori, S Ghera.   

Abstract

We performed a randomised controlled study to compare heparin with the A-V Impulse System in the prevention of deep-vein thrombosis (DVT) in 132 consecutive patients undergoing total hip replacement. After the operation, all patients had compression stockings, 65 were treated with calcium heparin and 67 with the intermittent plantar pump. DVT was diagnosed by Doppler ultrasound and thermography, followed by phlebography. There were 23 cases of DVT (35.4%) in the heparin group, with 16 major and seven minor thromboses. In the impulse pump group there were nine cases (13.4%) with three major and six minor thromboses. The differences for all thromboses and for major thromboses were both significant at p < 0.005. In the heparin group there was one fatal pulmonary embolism and nine patients (13.8%) had excessive bleeding or wound haematomas, as against none in the impulse pump group.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027144

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  A novel approach to mechanical prophylaxis: calf impulse technology mimics natural ambulation more effectively than sequential calf compression.

Authors:  David J Warwick; Keith Dewbury
Journal:  Int J Angiol       Date:  2008

2.  Flowtron foot-pumps for prevention of venous thromboembolism in total hip and knee replacement.

Authors:  Rocco P Pitto; Chuan K Koh
Journal:  J Orthop       Date:  2014-11-13

Review 3.  Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis.

Authors:  Robert W Eppsteiner; Jennifer J Shin; Jonas Johnson; Rob M van Dam
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

4.  Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty.

Authors:  C Windisch; W Kolb; K Kolb; P Grützner; R Venbrocks; J Anders
Journal:  Int Orthop       Date:  2010-07-22       Impact factor: 3.075

5.  Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial.

Authors:  Rocco P Pitto; Simon Young
Journal:  Int Orthop       Date:  2007-02-15       Impact factor: 3.075

6.  Evidence-based compression: prevention of stasis and deep vein thrombosis.

Authors:  Rhys J Morris; John P Woodcock
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

7.  Can a new design of pneumatic compression device reduce variations in delivered therapy for the mechanical prophylaxis of thromboembolic disease after total hip arthroplasty?

Authors:  Bassam A Masri; David J Dunlop; James A McEwen; Donald S Garbuz; Clive P Duncan
Journal:  Can J Surg       Date:  2004-08       Impact factor: 2.089

8.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10

Review 9.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

10.  Effect on deep venous thrombosis with flexion during total knee arthroplasty.

Authors:  Geoffrey H Westrich; Raz Winiarsky; Michael Betsy; Lena Maun; Thomas P Sculco
Journal:  HSS J       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.